Features and Long-Term Outcomes of Stage IV Melanoma Patients Achieving Complete Response Under Anti-PD-1-Based Immunotherapy

BACKGROUND: Immune checkpoint inhibition (ICI) has changed the melanoma treatment spectrum. Few studies have examined the characteristics and long-term outcomes of patients achieving complete response (CR) under ICI. MATERIALS AND METHODS: We evaluated patients with unresectable stage IV melanoma tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Chatziioannou, Eftychia, Leiter, Ulrike, Thomas, Ioannis, Keim, Ulrike, Seeber, Olivia, Meiwes, Andreas, Boessenecker, Isabell, Gonzalez, Stephanie Sanchez, Torres, Francisco Merraz, Niessner, Heike, Sinnberg, Tobias, Forschner, Andrea, Flatz, Lukas, Amaral, Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195722/
https://www.ncbi.nlm.nih.gov/pubmed/37142875
http://dx.doi.org/10.1007/s40257-023-00775-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195722/
https://www.ncbi.nlm.nih.gov/pubmed/37142875
http://dx.doi.org/10.1007/s40257-023-00775-7

Ejemplares similares